Biotech

Verve Therapeutics Halts Gene Editing Trial After Side Effects

Verve halts enrollment in lead trial following grade 3 side effects and prioritizes next steps for PCSK9 editing therapy.

Hit-and-run Epigenome Editing: Gene Therapy Advancements

This study introduces a groundbreaking genetic engineering approach with immense potential for precision medicine.

Advancements in Genome Editing: Zinc-Finger Conditioned Recombinases

New technology promises a safer and more precise way of treating genetic disorders.

Development in Synthetic Biology for Safe and Controlled CAR-T Cell Therapy

Explore the revolutionary developments in Synthetic Biology for enhancing the safety and control of CAR-T cell therapy.